Latest News

We are pleased to announce that our perspective paper, “Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation,” has been recognised as one of the top-cited articles of 2024–2025 in the Beilstein Journal of Nanotechnology.

ALERT consortium is showing is moving fast towards it aim with a renewed optimising spirit! The first technical meeting has concluded and the scenario is clear: the development of multi-analyte devise for minimally invasive Alzheimer’s disease diagnosis is a complex and ambitus task.

We are thrilled to announce our participation in BIO-NANOAGE, a newly funded 12-month ECIU Research Seed Project entitled “Modern Cosmeceutical: Traditional Plant Extracts vs Nanoparticle Products as Potential Anti-Aging Factors,” this project officially kicked off with an in-person meeting in Łódź, Poland.

We are delighted to share that Prof. Silvia Giordani has been appointed to the Governing Board of the European Materials Research Society (E-MRS). This is a great honour and an exciting opportunity to contribute to the activities and future development of the European materials research community.

We are pleased to announce a new thematic issue of the Beilstein Journal of Nanotechnology, Functional Materials at the Biointerface, co-edited by Prof. Silvia Giordani (Dublin City University), Dr. Francesco Calzaferri (Institut des Biomolecules Max Mousseron, Montpellier), and Dr.

The Giordani Group was delighted to participate in the 2026 Irish Neuro-Oncology Society (INOS) Meeting, held on 21 August 2026 at Trinity College Dublin. The meeting brought together researchers from across Ireland to share exciting developments in brain tumour research, foster collaboration, and highlight emerging approaches in neuro-oncology.

Boron/nitrogen co-doped carbon nano-onions (BN-CNOs) are an emergent carbon nanomaterial with high structural stability and excellent biocompatibility. They have recently been demonstrated as a viable platform for the targeted delivery of anticancer therapeutics; however, their biodegradation behaviour and impact on immune cells remain unexplored. Here, we investigated the enzymatic and …